# Cellebrite DI Ltd. (CLBT)

Source page: https://stoqly.net/companies/clbt

- **Ticker:** CLBT (Nasdaq)
- **Sector:** Information Technology / Services-Prepackaged Software
- **SEC CIK:** 0001854587
- **Latest annual report:** 20-F filed 2026-03-03 (https://www.sec.gov/Archives/edgar/data/1854587/000162828026013790/cele-20251231.htm)
- **Data updated:** 2026-11-09

## Key figures

- **Last close:** $12.70 on 2026-11-09 (+2.01% on the day)
- **Market cap:** $3.2B
- **P/E (trailing):** 41.0x
- **EPS, trailing 12 months:** $0.31
- **Revenue (FY2025):** $476M
- **Revenue growth:** +18.6%
- **Revenue growth, 5-year CAGR:** +19.5%
- **Gross margin:** 84.2%
- **Operating margin:** 14.0%
- **Net margin:** 16.5%
- **Free cash flow:** $160M
- **Free cash flow margin:** 33.7%
- **Return on equity:** 19.1%
- **Change in share count:** +19.3%
- **Piotroski F-score:** 4/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.6M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/clbt/figures.csv

| US$ millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 172 | 195 | 246 | 271 | 325 | 401 | 476 |
| Operating income | -2 | 9 | 14 | 1 | 33 | 57 | 66 |
| Net income | -2 | 6 | 71 | 121 | -81 | -283 | 78 |
| Diluted EPS (US$) | -0.08 | -0.08 | 0.44 | 0.59 | -0.43 | -1.35 | 0.31 |
| Operating cash flow | 16 | 67 | 36 | 21 | 102 | 132 | 174 |
| Free cash flow | 10 | 60 | 31 | 14 | 97 | 124 | 160 |
| Cash | 82 | 134 | 146 | 132 | 228 | 293 | 276 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.